Related Experiment Video
Updated: Jul 17, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Insight Into the Optimal Timing of Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement
Dae Yong Park1, Matheus Simonato2, Yousif Ahmad3
1Department of Medicine, Cook County Health, Chicago, IL.
Insights
Performing percutaneous coronary intervention (PCI) on the same day as transcatheter aortic valve replacement (TAVR) is linked to better outcomes. Concomitant PCI and TAVR reduces 90-day readmissions and acute kidney injury compared to TAVR shortly after PCI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Healthcare Outcomes Research
Background:
- Many patients undergoing transcatheter aortic valve replacement (TAVR) have coexisting coronary artery disease requiring revascularization.
- Optimal timing for percutaneous coronary intervention (PCI) in relation to TAVR is not well-established, impacting clinical decisions.
Purpose of the Study:
- To evaluate the impact of PCI timing on clinical outcomes and readmissions following TAVR.
- To compare outcomes across different intervals between PCI and TAVR procedures.
Main Methods:
- Retrospective analysis of the National Readmissions Database (2016-2019).
- Patients were stratified into three groups based on PCI-TAVR timing: same-day, TAVR ≤30 days post-PCI, and TAVR >30 days post-PCI.
- Comparison of in-hospital mortality, acute kidney injury, nonhome discharge, and 90-day readmissions.
Main Results:
- No significant difference in in-hospital mortality was observed across the PCI-TAVR timing groups.
- TAVR performed ≤30 days after PCI was associated with increased odds of acute kidney injury (aOR 1.49), nonhome discharge (aOR 1.53), and 90-day readmission (aOR 1.35) compared to same-day procedures.
- Concomitant PCI and TAVR demonstrated lower rates of 90-day readmissions and acute kidney injury.
Conclusions:
- Same-day PCI and TAVR is associated with favorable outcomes, including reduced acute kidney injury and 90-day readmissions.
- Performing TAVR shortly after PCI (≤30 days) is linked to poorer outcomes.
- Concomitant PCI and TAVR should be considered for select patients undergoing TAVR with coronary artery disease.
Abstract:
Patients being considered for transcatheter aortic valve replacement (TAVR) are frequently diagnosed with coronary artery disease. In patients requiring revascularization, there is a paucity of data informing when to perform percutaneous coronary artery intervention (PCI). We evaluated the impact of PCI timing on clinical outcomes and readmissions after TAVR. From the National Readmissions Database 2016 to 2019, we stratified the duration between PCI and TAVR into 3 groups: same-day PCI and TAVR, TAVR ≤30 days after PCI, and TAVR >30 days after PCI. We then compared primary and secondary outcomes among them. A total of 5207 patients were included, 1413 (27.1%) of whom underwent PCI and TAVR on the same day, while 2161 (41.5%) underwent TAVR ≤30 days after PCI, and 1632 (31.3%) underwent TAVR >30 days after PCI. There was no significant difference for in-hospital mortality among the groups (adjusted odds ratio [aOR] 0.49, 95% confidence interval [CI] 0.16-1.48, p = 0.203 for same-day versus ≤30 days; aOR 2.07, 95% CI 0.68-6.30, p = 0.199 for same-day versus >30 days). Patients who underwent TAVR ≤30 days after PCI had higher odds of acute kidney injury (aOR 1.49, 95% CI 1.05-2.10, p = 0.024), nonhome discharge (aOR 1.53, 95% CI 1.20-1.96, p = 0.001), and 90-day readmission (aOR 1.35, 95% CI 1.04-1.76, p = 0.026) compared with those who underwent same-day PCI and TAVR. Concomitant PCI and TAVR was associated with lower rates of 90-day readmissions and acute kidney injury compared with TAVR shortly after PCI (<30 days) and should be considered in select patients.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Aortic Regurgitation III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

